Latest filings (excl ownership)
6-K
Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023
5 Apr 24
6-K
LifeSci Partners, LLC
16 Feb 24
6-K
LifeSci Partners, LLC
16 Feb 24
424B3
Prospectus supplement
15 Feb 24
6-K
LifeSci Partners, LLC
1 Feb 24
6-K
Trinity Biotech Announces Acquisition of the CGM Assets of
1 Feb 24
6-K
Trinity Biotech Announces It Has Begun Shipments of Its New
2 Jan 24
6-K
Trinity Biotech Announces Management Changes
19 Dec 23
6-K
Trinity Biotech Receives Non-Compliance Notice Regarding
29 Nov 23
6-K
Current report (foreign)
10 Oct 23
6-K
Trinity Biotech Announces Q2 2023 Financial Results
6 Oct 23
6-K
Trinity Biotech Receives Non-Compliance Notice Regarding
12 Sep 23
6-K
This report has been prepared in accordance with the Irish Companies Act 2014
6 Sep 23
6-K
Current report (foreign)
5 Sep 23
6-K
Trinity Biotech Announces Q1 2023 Financial Results
10 Jul 23
20-F
2022 FY
Annual report (foreign)
16 May 23
6-K
Current report (foreign)
8 May 23
NT 20-F
Notice of late annual filing (foreign)
1 May 23
6-K
Current report (foreign)
1 May 23
6-K
Trinity Biotech Receives Non-Compliance Notice Regarding
25 Apr 23
6-K
First Amendment to Amended and Restated Credit Agreement and Guaranty
24 Apr 23
424B3
Prospectus supplement
31 Mar 23
EFFECT
Notice of effectiveness
30 Mar 23
6-K
Current report (foreign)
27 Mar 23
6-K
Trinity Biotech Announces Fourth Quarter and Fiscal Year 2022
27 Mar 23
POS AM
Prospectus update (post-effective amendment)
23 Mar 23
6-K
Amended and Restated Credit Agreement and Guaranty
22 Feb 23
6-K
Trinity Biotech Announces Strategic Partnership with imaware™ to Deliver Integrated Diagnostic Testing Solutions to Digital Health Industry
10 Jan 23
6-K
Trinity Biotech Announces Q3 2022 Financial Results
16 Dec 22
6-K
Trinity Biotech plc to Announce Third Quarter Fiscal Year 2022 Financial Results
9 Dec 22
6-K
Current report (foreign)
15 Nov 22
6-K
Trinity Biotech Announces Quarter 2 2022 Financial Results
4 Nov 22
6-K
Current report (foreign)
4 Nov 22
6-K
Trinity Biotech plc to Announce Second Quarter Fiscal Year 2022 Financial Results
2 Nov 22
6-K
Trinity Biotech Announces the Appointment of Tom Lindsay
27 Oct 22
6-K
Lytham Partners, LLC
4 Oct 22
6-K
Trinity Biotech Announces Results of AGM
30 Sep 22
6-K
Current report (foreign)
16 Sep 22
424B3
Prospectus supplement
15 Sep 22
EFFECT
Notice of effectiveness
15 Sep 22
Latest ownership filings
SC 13D
PERCEPTIVE ADVISORS LLC
9 Feb 24
SC 13D/A
MiCo IVD Holdings, LLC
2 Jan 24
SC 13D/A
MiCo Co., Ltd.
2 Jan 24
SC 13G/A
STONEHILL CAPITAL MANAGEMENT LLC
13 Feb 23
SC 13G/A
RENAISSANCE TECHNOLOGIES LLC
13 Feb 23
SC 13D
MiCo IVD Holdings, LLC
8 Dec 22
SC 13G/A
RENAISSANCE TECHNOLOGIES LLC
11 Feb 22
SC 13G
STONEHILL CAPITAL MANAGEMENT LLC
4 Feb 22
SC 13G/A
Whitefort Capital Master Fund, LP
16 Feb 21
SC 13G/A
STONEHILL CAPITAL MANAGEMENT LLC
12 Feb 21
SC 13G
RENAISSANCE TECHNOLOGIES LLC
10 Feb 21
SC 13G/A
STONEHILL CAPITAL MANAGEMENT LLC
4 Sep 20
SC 13G/A
Trinity Biotech PLC
14 Feb 20
SC 13G/A
Trinity Biotech PLC
14 Feb 20
SC 13G/A
Trinity Biotech PLC
7 Feb 20
SC 13G/A
Trinity Biotech PLC
8 Jul 19
SC 13G
Trinity Biotech PLC
3 May 19
SC 13G/A
Trinity Biotech PLC
14 Feb 19
SC 13G/A
Trinity Biotech PLC
12 Feb 19
SC 13G/A
Trinity Biotech PLC
12 Feb 19
SC 13G/A
Trinity Biotech PLC
10 Dec 18
SC 13G
Trinity Biotech PLC
17 Sep 18
SC 13G/A
Trinity Biotech PLC
9 Apr 18
SC 13G/A
Trinity Biotech PLC
15 Feb 18
SC 13G
Trinity Biotech PLC
14 Feb 18
SC 13G/A
Trinity Biotech PLC
14 Feb 18
SC 13G/A
Trinity Biotech PLC
13 Feb 18
SC 13G/A
Trinity Biotech PLC
12 Feb 18
SC 13G/A
Trinity Biotech PLC
8 Feb 18
SC 13G/A
Trinity Biotech PLC
2 Feb 18
SC 13G/A
Trinity Biotech PLC
4 Aug 17
SC 13G/A
Trinity Biotech PLC
10 May 17
SC 13G
Trinity Biotech PLC
15 Mar 17
SC 13G/A
Trinity Biotech PLC
14 Feb 17
SC 13G/A
Trinity Biotech PLC
13 Feb 17
SC 13G/A
Trinity Biotech PLC
10 Feb 17
SC 13G/A
Trinity Biotech PLC
6 Feb 17
SC 13G/A
Trinity Biotech PLC
2 Feb 17
SC 13G
Trinity Biotech PLC
2 Nov 16
SC 13G
Trinity Biotech PLC
16 Feb 16